Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Insufficient |
In the current state of the dossier and while awaiting the results of the VEG 108844 non-inferiority study comparing VOTRIENT with sunitinib, the Transparency Committee considers that the actual benefit is insufficient to justify reimbursement by National Health Insurance. |
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
6NWwzcTAgZeC2k0z
